IO Biotech, Inc.
Current role
IOBTQ
Qasim Ahmad, M.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Qasim Ahmad, M.D.
IO Biotech, Inc. reported in an 8-K filed January 30, 2026 that Qasim Ahmad, M.D. was terminated as Chief Medical Officer, effective February 15, 2026. IO Biotech, Inc. reported in an 8-K filed July 18, 2023 that Qasim Ahmad, M.D. was appointed Chief Medical Officer, effective July 15, 2023.
“on January 28, 2026, the Company notified Qasim Ahmad, M.D., the Company's Chief Medical Officer and a named executive officer, that his employment with the Company would end effective as of the close of business on February 15, 2026.”
“On July 15, 2023, IO Biotech, Inc. (the “Company”) appointed Qasim Ahmad, M.D. as the Company’s Chief Medical Officer, effective as of that same date.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
IO Biotech, Inc. (IOBTQ)
SEC 8-K
Current2023-07-15–present
-
IO Biotech, Inc. (IOBTQ)
SEC 8-K
2023-07-15–2026-02-15
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at IO Biotech, Inc.
Other people whose current roles at this company are on record from its filings.
- Amy Sullivan CFO
- Devin W. Smith General Counsel
- Heidi Hunter Board Member
- Helen Collins, M.D. Board Member
- Mai-Britt Zocca Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.